The Government of Puerto Rico allocated $14.9 million from the American Rescue Plan Act (ARPA), to create the Grants Program for Research & Development of Covid-19 Treatments. The Program will be administered by the Coronavirus Relief Fund Disbursement Oversight Committee (Committee) in conjunction with the Puerto Rico Department of Economic Development and Commerce (PR-DEDC), and the Puerto Rico Fiscal Agency and Financial Advisory Authority (AAFAF).
Investment: $14,871,187
Restrictions: Given the stage of the pandemic, Puerto Rico has identified an opportunity of accelerating the development of new medications and treatments for COVID-19. This will also be an opportunity to further stimulate the Life Science economic sector in Puerto Rico, promoting the drug and product discovery with research and development programs, such as this one. This will be a grants program for research and development projects for the development of new treatments and or/ drugs to treat COVID-19. The projects evaluated can be either academic projects or projects performed by companies. All will be evaluated and scored based on public health impact and its economic development potential.
Disbursement of Program funds will be subject to the strictest standards to ensure compliance with federal regulations and best practices. Therefore, each request for disbursement will be duly documented and subject to control and audit.
- Click HERE to download the Program Guidelines